Literature DB >> 29035751

Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.

Shi Zhang1, Erez Eitan1, Tsung-Yu Wu1, Mark P Mattson2.   

Abstract

Parkinson's disease (PD) is characterized by accumulations of toxic α-synuclein aggregates in vulnerable neuronal populations in the brainstem, midbrain, and cerebral cortex. Recent findings suggest that α-synuclein pathology can be propagated transneuronally, but the underlying molecular mechanisms are unknown. Advances in the genetics of rare early-onset familial PD indicate that increased production and/or reduced autophagic clearance of α-synuclein can cause PD. The cause of the most common late-onset PD is unclear, but may involve metabolic compromise and oxidative stress upstream of α-synuclein accumulation. As evidence, the lipid peroxidation product 4-hydroxynonenal (HNE) is elevated in the brain during normal aging and moreso in brain regions afflicted with α-synuclein pathology. Here, we report that HNE increases aggregation of endogenous α-synuclein in primary neurons and triggers the secretion of extracellular vesicles (EVs) containing cytotoxic oligomeric α-synuclein species. EVs released from HNE-treated neurons are internalized by healthy neurons which as a consequence degenerate. Levels of endogenously generated HNE are elevated in cultured cells overexpressing human α-synuclein, and EVs released from those cells are toxic to neurons. The EV-associated α-synuclein is located both inside the vesicles and on their surface, where it plays a role in EV internalization by neurons. On internalization, EVs harboring pathogenic α-synuclein are transported both anterogradely and retrogradely within axons. Focal injection of EVs containing α-synuclein into the striatum of wild-type mice results in spread of synuclein pathology to anatomically connected brain regions. Our findings suggest a scenario for late-onset PD in which lipid peroxidation promotes intracellular accumulation and then extrusion of EVs containing toxic α-synuclein species; the EVs are then internalized by adjacent neurons, so propagating the neurodegenerative process. Published by Elsevier Inc.

Entities:  

Keywords:  4-hydroxynonenal; Exosomes; Extracellular vesicles; Lipid peroxidation; Parkinson's disease; Striatum; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 29035751      PMCID: PMC5705257          DOI: 10.1016/j.neurobiolaging.2017.09.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  84 in total

1.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

2.  Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.

Authors:  James T Lee; Tiffany C Wheeler; Lian Li; Lih-Shen Chin
Journal:  Hum Mol Genet       Date:  2007-12-07       Impact factor: 6.150

3.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

4.  Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Virginia M-Y Lee
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

Review 5.  Synuclein deposition and non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2011-05-12       Impact factor: 3.181

Review 6.  Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin.

Authors:  Nicoletta Plotegher; Luigi Bubacco
Journal:  Ageing Res Rev       Date:  2015-12-09       Impact factor: 10.895

7.  4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease.

Authors:  R Shringarpure; T Grune; N Sitte; K J Davies
Journal:  Cell Mol Life Sci       Date:  2000-11       Impact factor: 9.261

8.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

View more
  20 in total

Review 1.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

Review 2.  Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.

Authors:  Richard J Karpowicz; John Q Trojanowski; Virginia M-Y Lee
Journal:  Lab Invest       Date:  2019-02-13       Impact factor: 5.662

3.  Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.

Authors:  Sophia M Raefsky; Ran Furman; Ginger Milne; Erik Pollock; Paul Axelsen; Mark P Mattson; Mikhail S Shchepinov
Journal:  Neurobiol Aging       Date:  2018-03-05       Impact factor: 4.673

Review 4.  Bidirectional Microglia-Neuron Communication in Health and Disease.

Authors:  Zsuzsanna Szepesi; Oscar Manouchehrian; Sara Bachiller; Tomas Deierborg
Journal:  Front Cell Neurosci       Date:  2018-09-27       Impact factor: 5.505

5.  Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Flora Guerra; Giulia Girolimetti; Raffaella Beli; Marco Mitruccio; Consiglia Pacelli; Anna Ferretta; Giuseppe Gasparre; Tiziana Cocco; Cecilia Bucci
Journal:  Cells       Date:  2019-05-14       Impact factor: 6.600

6.  Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice.

Authors:  Yun Sun; Qianyun Mao; Chao Shen; Chen Wang; Weiping Jia
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-08       Impact factor: 3.168

7.  Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes.

Authors:  David W Freeman; Nicole Noren Hooten; Erez Eitan; Jamal Green; Nicolle A Mode; Monica Bodogai; Yongqing Zhang; Elin Lehrmann; Alan B Zonderman; Arya Biragyn; Josephine Egan; Kevin G Becker; Mark P Mattson; Ngozi Ejiogu; Michele K Evans
Journal:  Diabetes       Date:  2018-05-02       Impact factor: 9.337

Review 8.  Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.

Authors:  Xian-Si Zeng; Wen-Shuo Geng; Jin-Jing Jia; Lei Chen; Peng-Peng Zhang
Journal:  Front Aging Neurosci       Date:  2018-04-17       Impact factor: 5.750

Review 9.  Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin.

Authors:  Bor Luen Tang
Journal:  Cells       Date:  2018-06-14       Impact factor: 6.600

Review 10.  Extracellular Vesicles in Alzheimer's and Parkinson's Disease: Small Entities with Large Consequences.

Authors:  Charysse Vandendriessche; Arnout Bruggeman; Caroline Van Cauwenberghe; Roosmarijn E Vandenbroucke
Journal:  Cells       Date:  2020-11-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.